<circle stroke="#1e77f9" class="srdi68r9" cx="25" cy="25" r="20" fill="none" stroke-width="5">

Eli Lilly threatens Zepbound copycat makers after shortage, Bloomberg reports

CHRO

PremiumThe Fly

4d ago

Biotech Alert: Searches spiking for these stocks today

PremiumThe Fly

5d ago

CDT

Novo Nordisk’s Market Leadership Bolstered by Strong Product Data and Promising Future Assets

PremiumRatings

5d ago

PremiumThe FlyNovo Nordisk presents results from STRIDE study on Ozempic

5d ago

Confident Buy Rating for Novo Nordisk Amid Sales Guidance Adjustments and Market Challenges

Ratings

Confident Buy Rating for Novo Nordisk Amid Sales Guidance Adjustments and Market Challenges

8d ago

Novo Nordisk price target lowered to DKK 910 from DKK 1,075 at BofA

The Fly

Novo Nordisk price target lowered to DKK 910 from DKK 1,075 at BofA

8d ago

Lexicon announces exclusive license agreement with Novo Nordisk for LX9851

PremiumThe Fly

8d ago

Novo Nordisk price target lowered to DKK 600 from DKK 700 at Morgan Stanley

LXRX

PremiumThe Fly

9d ago

Novo Nordisk call volume above normal and directionally bullish

PremiumThe Fly

9d ago

Hold Rating for Novo Nordisk Amid Competitive Pressures and Market Uncertainties

PremiumRatings

9d ago

PremiumThe FlyNovo Nordisk, The United Laboratories announce license agreement for UBT251

10d ago

Novo Nordisk price target lowered to DKK 610 from DKK 725 at Berenberg

The Fly

Novo Nordisk price target lowered to DKK 610 from DKK 725 at Berenberg

11d ago

Strategic Positioning and Growth Potential: Evan Seigerman’s Buy Rating on Novo Nordisk

Ratings

Strategic Positioning and Growth Potential: Evan Seigerman’s Buy Rating on Novo Nordisk

11d ago

Novo Nordisk expands Wegovy $499-per-month offering

PremiumThe Fly

12d ago

Novo Nordisk’s etavopivat granted FDA orphan designation in thalassemia

PremiumThe Fly

14d ago

Eli Lilly launches weight-loss drug Mounjaro in India, Reuters says

PremiumThe Fly

16d ago

Hims & Hers to keep offering compounded Ozempic, Wegovy, WSJ reports

PremiumThe Fly

16d ago

PremiumThe FlyTrump Trade: Administration explores simplified plans for reciprocal tariffs

18d ago

Big pharma fears drug price spikes in US-EU tariff spat, Reuters says

The Fly

Big pharma fears drug price spikes in US-EU tariff spat, Reuters says

18d ago

AZN

BMY

FDA voices ‘concerns’ with unapproved GLP-1 drugs used for weight loss

The Fly

FDA voices ‘concerns’ with unapproved GLP-1 drugs used for weight loss

19d ago